Recombinant multi-species REST protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine REST protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene was initially identified as a transcriptional repressor that represses neuronal genes in non-neuronal tissues. However, depending on the cellular context, this gene can act as either an oncogene or a tumor suppressor. The encoded protein is a member of the Kruppel-type zinc finger transcription factor family. It represses transcription by binding a DNA sequence element called the neuron-restrictive silencer element. The protein is also found in undifferentiated neuronal progenitor cells and it is thought that this repressor may act as a master negative regulator of neurogenesis. Alternatively spliced transcript variants have been described. [provided by RefSeq, May 2018]
The Alternative Names of target: 2610008J04Rik,DFNA27,GINGF5,HGF5,NRSF,Neural-restrictive silencer factor,Nrsf,RE1-silencing transcription factor,REST,REST4,RESTB,Rest,WT6,X2 box repressor,XBR

Target products collectionGo to REST products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP10889-Ag-1/ GM-Tg-hg-IP10889-Ag-2 Human REST protein Human
GM-Tg-rg-IP10889-Ag-1/ GM-Tg-rg-IP10889-Ag-2 Rat REST protein Rat
GM-Tg-mg-IP10889-Ag-1/ GM-Tg-mg-IP10889-Ag-2 Mouse REST protein Mouse
GM-Tg-cynog-IP10889-Ag-1/ GM-Tg-cynog-IP10889-Ag-2 Cynomolgus/Rhesus macaque REST protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP10889-Ag-1/ GM-Tg-felg-IP10889-Ag-2 Feline REST protein Feline
GM-Tg-cang-IP10889-Ag-1/ GM-Tg-cang-IP10889-Ag-2 Canine REST protein Canine
GM-Tg-bovg-IP10889-Ag-1/ GM-Tg-bovg-IP10889-Ag-2 Bovine REST protein Bovine
GM-Tg-equg-IP10889-Ag-1/ GM-Tg-equg-IP10889-Ag-2 Equine REST protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP10889-Ag-1/ GM-Tg-hg-IP10889-Ag-2; GM-Tg-rg-IP10889-Ag-1/ GM-Tg-rg-IP10889-Ag-2;
GM-Tg-mg-IP10889-Ag-1/ GM-Tg-mg-IP10889-Ag-2; GM-Tg-cynog-IP10889-Ag-1/ GM-Tg-cynog-IP10889-Ag-2;
GM-Tg-felg-IP10889-Ag-1/ GM-Tg-felg-IP10889-Ag-2; GM-Tg-cang-IP10889-Ag-1/ GM-Tg-cang-IP10889-Ag-2;
GM-Tg-bovg-IP10889-Ag-1/ GM-Tg-bovg-IP10889-Ag-2; GM-Tg-equg-IP10889-Ag-1/ GM-Tg-equg-IP10889-Ag-2
Products Name REST protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name REST
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine REST protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.